Today: 29 June 2026
Browse Category

NASDAQ:NRIX 8 December 2025 - 8 June 2026

Cathie Wood Sells $40M in Tesla, Keeps Cutting Iridium, and Adds Nurix: What ARK Invest’s Latest Trades Signal on Dec. 15, 2025

Cathie Wood Sells $40M in Tesla, Keeps Cutting Iridium, and Adds Nurix: What ARK Invest’s Latest Trades Signal on Dec. 15, 2025

ARK Invest sold nearly 88,000 Tesla shares worth about $39.3 million across its ARKK and ARKW funds on December 12. The firm also trimmed positions in Iridium Communications and added to biotech firm Nurix Therapeutics, while increasing stakes in Robinhood and Block. The moves come as markets remain volatile after a tech-led pullback and ahead of major central bank decisions.
Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Dyne Therapeutics shares fell 16.9% to $18.44 after announcing a $300 million stock offering. SLM Corp dropped 15%, Kontoor Brands slid 9.5%, and Waystar Holding lost 8.4%. Major indexes were little changed as investors awaited the Federal Reserve’s interest-rate decision. The U.S. 10-year Treasury yield hovered near 4.19%.
Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025

Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025

Nurix Therapeutics shares jumped about 20% to $21.70 intraday on December 8, 2025, after new Phase 1 data for its BTK degrader bexobrutideg (NX-5948) in blood cancers was presented at the ASH Annual Meeting. The company reported an 83% response rate in relapsed/refractory CLL/SLL patients and scheduled a webcast for the evening. Volume was well above normal, with shares trading near a 52-week high.

Stock Market Today

  • IMF Research Questions Bonds as Safe Havens in Stock Market Crashes, Suggests Commodities ETFs
    June 28, 2026, 10:12 PM EDT. Recent IMF research reveals that bonds may no longer serve as reliable diversifiers during stock market downturns due to increased positive correlation with stocks since 2019. Traditional wisdom that bonds rise when stocks fall is challenged. Instead, adding commodities like precious metals could offer better portfolio protection. ETFs such as iShares Silver Trust (SLV), which tracks silver bullion and has returned 21.75% annually over five years, and VanEck Rare Earth and Strategic Metals ETF (REMX) provide exposure to these assets. Silver's sharp 147.9% gain in 2025 reflects inflation concerns and industrial demand but also comes with volatility, having dropped 50% since its January peak. Investors should weigh risks carefully when seeking diversification beyond stocks and bonds.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Go toTop